• linkedin
  • Increase Font
  • Sharebar

    HBV reactivation with direct acting antivirals for HCV is highly manageable

    Direct-acting antiviral agents (DAAs) are a safe and highly effective treatment for hepatitis C virus (HCV) infection and, with proper screening, monitoring and treatment, reactivation of hepatitis B virus (HBV) is a manageable adverse event, according to a new study.

    Recent reports have noted HBV reactivation in patients with HBV–HCV co-infection. The Food and Drug Administration (FDA) has asked the manufacturers of DAAs to update their labeling to indicate the potential for HBV reactivation with treatment. In September 2016, updated guidance from the American Association for the Study of Liver Diseases and the Infectious Disease Society of America reviewed new information about the risk of HBV infection reactivation in patients who are co-infected and who clear HCV with DAAs. The mechanism for HBV reactivation with DAA therapy remains unknown.

    The researchers published their results on April 25, 2017 in Annals of Internal Medicine.

    HBV reactivation, defined as an abrupt increase in HBV replication in patients with inactive or resolved HBV infection, may result in clinically significant hepatitis, stated researchers led by Susan Bersoff-Matcha, MD, a medical officer with the FDA, located in Silver Spring, Maryland.

    “DAAs remain a safe and highly effective treatment for the management of HCV infection, and are a well-tolerated class of medications that may be administered by more primary care physicians and physician extenders in the future,” Bersoff-Matcha told Medical Economics.

    “The goal of our paper was to make sure all physicians are aware of the possibility of the HBV reactivation risk in patients co-infected with HBV-HCV who are initiating HCV DAAs,” she said. “In patients with serologic evidence of HBV infection, FDA recommends that physicians should monitor for clinical and laboratory signs of hepatitis flare or HBV reactivation during DAA therapy and during post-treatment follow up. Antiviral therapy for HBV infection should be given if criteria for HBV treatment are met.” 


    Next: Study details

    Mark L. Fuerst
    Staff Correspondent

    1 Comment

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • [email protected]
      I was diagnosed with hepatitis B six years ago when I became pregnant with my first child. My husband got tested for the virus as well but the results turned out negative. I had no idea how or where I contracted that virus. I had no signs or symptoms before the test. Last year I was getting some burning sensations in both feet and insomnia. I have not had any medications. December 2017 our family doctor started me on Green House Herbal Clinic Hepatitis B Virus Herbal mixture, 5 weeks into treatment I improved dramatically. At the end of the full treatment course, the disease is totally under control. No case of insomnia, burning feet, or weakness. Visit Green House Herbal Clinic official website www. greenhouseherbalclinic .com. I am strong again and able to go about daily activities.‌ This Herbal Formula is Incredible!! My life is back.

    Latest Tweets Follow